Bill > A01017

This bill amends the New York public health law to expand the Department of Health's existing program on drug-induced movement disorders by requiring the development and dissemination of educational materials for healthcare providers about these disorders. Specifically, the bill mandates that the educational materials cover screening and identifying symptoms of drug-induced movement disorders, treatment options, and methods to reduce stigma for people experiencing these disorders in connection with mental health treatment. The materials must be developed in consultation with the Commissioner of Mental Health and distributed in coordination with healthcare provider groups, drawing on best practices from professional organizations like the American Psychiatric Association. The bill aims to improve healthcare providers' understanding and awareness of drug-induced movement disorders, which can be side effects of certain mental health medications, and to support patients experiencing these conditions by promoting comprehensive, stigma-free care.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/A1017